The board of directors Merck (NYSE:MRK) authorised a dividend of USD0.65 per share of the company's common stock for the third quarter of 2021, it declared on Tuesday.
This dividend is payable on 7 July 2021 to shareholders of record at the close of business as of 15 June 2021.
According to the biopharmaceutical company, it has been bringing forward medicines and vaccines for many of the world's most challenging diseases and is at the forefront of research to prevent and treat diseases including cancer, HIV and Ebola.
Danaher Corporation announces quarterly cash dividend
Abbott announces quarterly common dividend
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva